Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
A Q&A with Nithin Stephen As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities...
In this Q&A, Nicholas Kirian, Senior Manager of MSAT, discusses how DAR-T™, an autologous CAR-T platform, is addressing longstanding challenges in...
Published by PharmaVoice In the rapidly evolving landscape of biopharmaceuticals, the integration of robust digital systems has become paramount....
Published byDrug Development & Delivery Growing R&D activities, personalized medicines, large-scale production of biologics, and access to new...
A Q&A with Nithin Stephen As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities...
Cell therapies offer life-changing treatments for patients with limited options, but face commercialization challenges due to high costs, ability to...
Drug Development & Delivery recently interviewed Susan Billings, Ph.D., Chief Commercial Officer of Resilience, to discuss pressing issues in the...